glp-1 kidney outcomes news Renal effects of receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future | Endocrine GLP-1 and the kidney: from

However, some peptides, such as semaglutide and tirzepatide, are FDA-approved for weight loss under brand names Wegovy and Zepbound, respectively

Monthly monitoring at stable dose: Once you reach your target dose and heart rate has stabilized (typically after 2 to 3 weeks at the same dose), weekly monitoring can shift to monthly spot checks

Using expired reconstituted tirzepatide carries all the same risks discussed above, plus additional contamination concerns if the bacteriostatic water preservative has degraded

Tirzepatide follows a similar long-term protocol as Semaglutide, with weight loss achieved over time in combination with a healthy diet and exercise